Home LiteratureArticle Details
PMID: 12963810 Published · ppublish English Comment Journal Article Research Support, U.S. Gov't, P.H.S.

Extending the utility of gene profiling data by bridging microarray platforms.

Ferl GZ, Timmerman JM, Witte ON

Abstract

暂无摘要

MeSH Terms
DNA, Complementary Disease/classification Gene Expression Profiling Humans Models, Statistical Oligonucleotide Array Sequence Analysis
Chemicals
DNA, Complementary
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Ferl Gregory Z
Biocybernetics Laboratory, Biomedical Engineering Interdepartmental Program, University of California, Los Angeles 90095, USA.
Timmerman John M
Witte Owen N
References (17)
17 references, click to expand
  1. International Consensus Conference on High-Dose Therapy with Hematopoietic Stem Cell Transplantation in Aggressive Non-Hodgkin's Lymphomas: report of the jury.
    J Clin Oncol. 1999 Jan;17(1):423-9 PMID: 10458261
  2. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.
    Nature. 2000 Feb 3;403(6769):503-11 PMID: 10676951
  3. Molecular portraits of human breast tumours.
    Nature. 2000 Aug 17;406(6797):747-52 PMID: 10963602
  4. Computational analysis of microarray data.
    Nat Rev Genet. 2001 Jun;2(6):418-27 PMID: 11389458
  5. Expression of a single gene, BCL-6, strongly predicts survival in patients with diffuse large B-cell lymphoma.
    Blood. 2001 Aug 15;98(4):945-51 PMID: 11493437
  6. Predicting the clinical status of human breast cancer by using gene expression profiles.
    Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):11462-7 PMID: 11562467
  7. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning.
    Nat Med. 2002 Jan;8(1):68-74 PMID: 11786909
  8. Gene expression profiling predicts clinical outcome of breast cancer.
    Nature. 2002 Jan 31;415(6871):530-6 PMID: 11823860
  9. Microarray and histopathological analysis of tumours: the future and the past?
    Nat Rev Cancer. 2001 Nov;1(2):151-7 PMID: 11905806
  10. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.
    N Engl J Med. 2002 Jun 20;346(25):1937-47 PMID: 12075054
  11. Design issues for cDNA microarray experiments.
    Nat Rev Genet. 2002 Aug;3(8):579-88 PMID: 12154381
  12. Microarrays: the use of oligonucleotides and cDNA for the analysis of gene expression.
    Drug Discov Today. 2003 Feb 1;8(3):134-41 PMID: 12568783
  13. Statistical tests for differential expression in cDNA microarray experiments.
    Genome Biol. 2003;4(4):210 PMID: 12702200
  14. Increasing chemotherapy intensity in aggressive lymphomas: a renewal?
    J Clin Oncol. 2003 Jul 1;21(13):2457-9 PMID: 12829662
  15. A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma.
    Proc Natl Acad Sci U S A. 2003 Aug 19;100(17):9991-6 PMID: 12900505
  16. A predictive model for aggressive non-Hodgkin's lymphoma.
    N Engl J Med. 1993 Sep 30;329(14):987-94 PMID: 8141877
  17. Cluster analysis and display of genome-wide expression patterns.
    Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14863-8 PMID: 9843981
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
2003-09-16
Epub
2003-00-08
Pages
10585-7
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC196845
Subset
IM
Grants
NCI NIH HHS · T32 CA009120 · United States
NCI NIH HHS · 5-T32-CA009120-28 · United States
Corrections
CommentOn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]